News & Resources

THG Digital 9/8/25 THG Digital 9/8/25

From Patients To Consumers: Direct-To-Consumer Pricing As A Model For Healthcare Reform

Read More

THG Digital 8/18/25 THG Digital 8/18/25

Trump Is Making Healthcare A Winning “80/20” Political Issue For GOP

Read More

THG Digital 8/14/25 THG Digital 8/14/25

Op-Ed: Terry Wilcox: Why Most Favored Nation pricing risks putting America last

Read More

THG Digital 8/13/25 THG Digital 8/13/25

New “Most Favored Patient” Reform Initiative: A Bold Policy Blueprint for Lower Costs, Greater Access and Better Healthcare

Read More

THG Digital 8/11/25 THG Digital 8/11/25

Trump can rein in healthcare costs AND win medical breakthroughs — here’s how

Read More

THG Digital 8/8/25 THG Digital 8/8/25

Drugmakers Are Embracing Direct-To-Consumer Sales. That's Fantastic News For Patients.

Read More

THG Digital 8/1/25 THG Digital 8/1/25

Trump Fixed NATO. He Can Fix Prescription Drug Prices Too

Read More

THG Digital 7/21/25 THG Digital 7/21/25

The Big Beautiful Bill Fixes One Drug Problem—But Highlights An Even Bigger One

Read More

THG Digital 7/14/25 THG Digital 7/14/25

The Culprit Impeding Drug Competition Is Not Who The Feds Expected

Read More

THG Digital 7/14/25 THG Digital 7/14/25

Buchanan, Arrington Lead Letter on Foreign Freeloading on American-Financed Innovation to U.S. Trade Representative

Read More

THG Digital 7/2/25 THG Digital 7/2/25

Drugs Are Cheaper Here Than Abroad, and Other Countries Should Adopt Our Model

Read More

THG Digital 7/2/25 THG Digital 7/2/25

Drugs Are Cheaper Here Than Abroad, and Other Countries Should Adopt Our Model

Read More

THG Digital 6/25/25 THG Digital 6/25/25

The cost of misaligned incentives in the pharmaceutical supply chain

Read More

THG Digital 6/23/25 THG Digital 6/23/25

Everybody Loses with Most Favored Nation Reference Pricing. . .Except China.

Read More

THG Digital 6/17/25 THG Digital 6/17/25

New FDA Chief Wants to Fast-Track Some Drugs, Use More AI

Read More